UNSPSC 51294603: Minaprine hydrochloride

This classification denotes an antidepressant agent with the molecular formula C17H22N4O.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 82Y7NT6DFT, chemically known as 4-morpholineethanamine, n- (4-methyl-6-phenyl-3-pyridazinyl)-, dihydrochloride but more generally known as minaprine hydrochloride, which bears US NIH Compound Identifier 4199. Most nations, for tariff and trade purposes, schedule minaprine hydrochloride under HS 29349990. As of Q4 2014, MINAPRINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity.

Minaprine hydrochloride bears US NLM identifiers UMLS ID C0951496 and NCI Concept Code C80005. SMILES: CC1CC(NNC1NCCN2CCOCC2)C3CCCCC3.CL.CL.

UNSPSC 51294603 Minaprine hydrochloride is a Commodity code that does not align with the recent state and local solicitations posted under it. The code nominally identifies a specific pharmaceutical compound (minaprine hydrochloride, an antidepressant), but the three recent opportunities tagged to this code address different product categories: naloxone and drug deactivation systems (Seminole County, Florida), direct-to-manufacturer prescription programs (Texas Health and Human Services Commission), and generic multi-source pharmaceuticals and OTC products through cooperative purchasing (Minnesota Multistate Cooperative Purchasing Alliance). None of these solicitations seek minaprine hydrochloride specifically. The mismatch suggests either miscoding in the source data or a broader tagging practice that does not reflect the commodity's actual procurement scope.

Given the misalignment between the code name and recent opportunities, this code shows little relevant activity for vendors focused on minaprine hydrochloride procurement. The recent opportunities represent pharmaceutical procurement more broadly—emergency response supplies, pharmacy benefit management infrastructure, and cooperative purchasing agreements for generic pharmaceuticals—rather than a market for this specific active pharmaceutical ingredient. Firms pursuing minaprine hydrochloride sales to state and local health systems should verify coding accuracy in source systems before building this code into their opportunity pipeline.